You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • A whole-blood RNA transcript-based gene signature is associated with the development of CTLA-4 blockade-related diarrhea in patients with advanced melanoma treated with the checkpoint inhibitor tremelimumab

Citation Tools

Article menu

Download PDFPDF

XML
Research Article
A whole-blood RNA transcript-based gene signature is associated with the development of CTLA-4 blockade-related diarrhea in patients with advanced melanoma treated with the checkpoint inhibitor tremelimumab

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Friedlander P, Wood K, Wassmann K, et al
A whole-blood RNA transcript-based gene signature is associated with the development of CTLA-4 blockade-related diarrhea in patients with advanced melanoma treated with the checkpoint inhibitor tremelimumab
Journal for ImmunoTherapy of Cancer 2018;6:90. doi: 10.1186/s40425-018-0408-9